This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1994 Dec;344(8939-8940):1768.

Scandinavian simvastatin study (4S)

D Grodos, R Tonglet

PMID: 7997017

Scandinavian simvastatin study (4S)

D Grodos et al. Lancet. 1994 Dec.

. 1994 Dec;344(8939-8940):1768.

Authors

D Grodos, R Tonglet

PMID: 7997017

No abstract available

PubMed Disclaimer

Similar articles

The 4S study. Implications for prescribing.
van Boven AJ, Brügemann J, de Graeff PA, May JF, Crijns HJ. van Boven AJ, et al. Drugs. 1996 Apr;51(4):507-14. doi: 10.2165/00003495-199651040-00001. Drugs. 1996. PMID: 8706591 Review.
Scandinavian simvastatin study (4S).
Smith GD, Pekkanen J. Smith GD, et al. Lancet. 1994 Dec 24-31;344(8939-8940):1766; author reply 1767-8. Lancet. 1994. PMID: 7864990 No abstract available.
Scandinavian simvastatin study (4S).
Manzato E. Manzato E. Lancet. 1994 Dec 24-31;344(8939-8940):1767; author reply 1767-8. Lancet. 1994. PMID: 7997016 No abstract available.
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
Johannesson M, Jönsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Johannesson M, et al. N Engl J Med. 1997 Jan 30;336(5):332-6. doi: 10.1056/NEJM199701303360503. N Engl J Med. 1997. PMID: 9011785
Simvastatin to lower cholesterol.
[No authors listed] [No authors listed] Drug Ther Bull. 1990 Apr 17;28(8):29-31. Drug Ther Bull. 1990. PMID: 2131246 Review. No abstract available.

See all similar articles

Cited by

Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.
Pharoah PD, Hollingworth W. Pharoah PD, et al. BMJ. 1996 Jun 8;312(7044):1443-8. doi: 10.1136/bmj.312.7044.1443. BMJ. 1996. PMID: 8664620 Free PMC article.
The 4S study. Implications for prescribing.
van Boven AJ, Brügemann J, de Graeff PA, May JF, Crijns HJ. van Boven AJ, et al. Drugs. 1996 Apr;51(4):507-14. doi: 10.2165/00003495-199651040-00001. Drugs. 1996. PMID: 8706591 Review.
The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.
Ramos SC, Fonseca FA, Kasmas SH, Moreira FT, Helfenstein T, Borges NC, Moreno RA, Rezende VM, Silva FC, Izar MC. Ramos SC, et al. Nutr J. 2011 Aug 2;10:80. doi: 10.1186/1475-2891-10-80. Nutr J. 2011. PMID: 21810257 Free PMC article. Clinical Trial.
The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease.
Fu G, Hu M, Chu L, Zhang M. Fu G, et al. Int J Endocrinol. 2015;2015:758402. doi: 10.1155/2015/758402. Epub 2015 May 18. Int J Endocrinol. 2015. PMID: 26089891 Free PMC article.
Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany.
Waßmuth S, Rohe K, Noack F, Noutsias M, Treede H, Schlitt A. Waßmuth S, et al. Vasc Health Risk Manag. 2019 Oct 31;15:477-483. doi: 10.2147/VHRM.S197089. eCollection 2019. Vasc Health Risk Manag. 2019. PMID: 31802881 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database